Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-20-000008
Filing Date
2020-11-05
Accepted
2020-11-05 08:29:40
Documents
80
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q anip-20200930x10q.htm   iXBRL 10-Q 2436042
2 EX-10.2 anip-20200930ex1020d6792.htm EX-10.2 75271
3 EX-31.1 anip-20200930ex311ac497b.htm EX-31.1 11361
4 EX-31.2 anip-20200930ex3129aae96.htm EX-31.2 10759
5 EX-32.1 anip-20200930ex32110df46.htm EX-32.1 8594
  Complete submission text file 0001023024-20-000008.txt   9472964

Data Files

Seq Description Document Type Size
6 EX-101.SCH anip-20200930.xsd EX-101.SCH 52229
7 EX-101.CAL anip-20200930_cal.xml EX-101.CAL 66452
8 EX-101.DEF anip-20200930_def.xml EX-101.DEF 214019
9 EX-101.LAB anip-20200930_lab.xml EX-101.LAB 399019
10 EX-101.PRE anip-20200930_pre.xml EX-101.PRE 396228
11 EXTRACTED XBRL INSTANCE DOCUMENT anip-20200930x10q_htm.xml XML 1990181
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 201288840
SIC: 2834 Pharmaceutical Preparations